Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy | Zendy

Aiyi Zhou | Zendy; Chenjing Zhou | Zendy; Jing Yao | Zendy; Yan-long Quan | Zendy; Bai-Chao Ren | Zendy; Jianming Wang | Zendy

Open Access

Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy

Author(s) -

Aiyi Zhou,

Chenjing Zhou,

Jing Yao,

Yan-long Quan,

Bai-Chao Ren,

Jianming Wang

Publication year - 2016

Publication title -

international journal of ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 29

eISSN - 2227-4898

pISSN - 2222-3959

DOI - 10.18240/ijo.2016.12.12

Subject(s) - medicine , panretinal photocoagulation , diabetic retinopathy , bevacizumab , ophthalmology , visual acuity , fluorescein angiography , adverse effect , intraocular pressure , diabetes mellitus , surgery , chemotherapy , endocrinology

To evaluate the effects of panretinal photocoagulation (PRP) compared with PRP plus intravitreal bevacizumab (IVB) in patients with high-risk proliferative diabetic retinopathy (PDR) according to the Early Treatment Diabetic Retinopathy Study criteria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research